Gary D. Tollefson, MD, PhD
- 10Articles
- 23.9KReads
- 1997–2005Active
- 30Collaborators
About
Gary D. Tollefson, MD, PhD, has published extensively on the treatment of schizophrenia, schizoaffective disorders, and major depressive disorder, with a focus on pharmacological interventions such as olanzapine and fluoxetine. His work includes controlled studies on treatment-resistant depression, comparisons of antipsychotic medications in managing negative symptoms, and investigations into weight changes and side effects associated with long-term antipsychotic use. Tollefson's research spans neurology and psychiatry, emphasizing clinical trials and safety profiles of psychiatric medications.
Publications
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
